Legal battle over semaglutide between Novo Nordisk and Indian drugmakers will set precedent for future opportunities and ...

Novo Nordisk’s semaglutide product to lose patent protection in China next year, according to L.E.K. Consulting.

Eli Lilly is a global healthcare giant, generating strong growth from a diverse portfolio of blockbuster medications. Viking ...

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

“While the term ‘Ozempic Butt’ may be new, the concept of being left with sagging skin after rapidly losing a large amount of ...

The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...

The large molecule injectable drugs market is anticipated to expand at a CAGR of ~9% during the forecast period. Key drivers ...

A doctor has explained why Ozempic use has her 'fearing for society' as she pointed out one problem with people taking the drug.

In some cases, counterfeit drugs have landed people in the hospital, including three people in the United States whose blood ...

New technology and drugs are transforming how doctors detect and treat silent liver disease MASLD before it leads to liver ...

Stocks such as Apollo Hospitals, IndiGo, Tata Motors, BPCL, Leela Hotels, and Aegis Vopak Terminals are expected to be in the ...